Riboflavin Kinase Market

Riboflavin Kinase is a vitamin that is needed for growth and overall good health. It helps the body break down carbohydrates, proteins and fats to produce energy, and it allows oxygen to be used by the body. In enzymology, Riboflavin Kinase is an enzyme that works as catalysis for ATP. Riboflavin is known as Vitamin B2 and is converted into flavin mononucleotide (FMN) and flavin adenine dinucleotide (FAD) by riboflavin kinase and FMN adenylyltransferase, respectively.

Riboflavin Kinase Market contains market size and forecasts of Riboflavin Kinase in global, including the following market information:

Global Riboflavin Kinase Market Revenue, 2018-2023, 2023-2030, ($ millions)

Global Riboflavin Kinase Market Sales, 2018-2023, 2023-2030, (Tons)

Global top five Riboflavin Kinase companies in 2022 (%)

The global Riboflavin Kinase market was valued at million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.

The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.

Feed Grade Segment to Reach $ Million by 2030, with a % CAGR in next six years.

The global key manufacturers of Riboflavin Kinase include DSM, BASF, NB Group, Shanghai Acebright Pharmaceuticals, Hubei Guangji Pharmaceutical, Ningxia Qiyuan Pharma, Hebei Shengxue Dacheng and Xinfa Pharmaceutical, etc. In 2022, the global top five players have a share approximately % in terms of revenue.

We surveyed the Riboflavin Kinase manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Riboflavin Kinase Market, by Type, 2018-2023, 2023-2030 ($ Millions) & (Tons)

Global Riboflavin Kinase Market Segment Percentages, by Type, 2022 (%)

Feed Grade

Food Grade

Pharma Grade

Global Riboflavin Kinase Market, by Application, 2018-2023, 2023-2030 ($ Millions) & (Tons)

Global Riboflavin Kinase Market Segment Percentages, by Application, 2022 (%)

Food Additives

Animal Feeding

Pharmaceutical

Health Supplements

Cosmetic And Personal Care

Others

Global Riboflavin Kinase Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions) & (Tons)

Global Riboflavin Kinase Market Segment Percentages, By Region and Country, 2022 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Riboflavin Kinase revenues in global market, 2018-2023 (Estimated), ($ millions)

Key companies Riboflavin Kinase revenues share in global market, 2022 (%)

Key companies Riboflavin Kinase sales in global market, 2018-2023 (Estimated), (Tons)

Key companies Riboflavin Kinase sales share in global market, 2022 (%)

Further, the report presents profiles of competitors in the market, key players include:

DSM

BASF

NB Group

Shanghai Acebright Pharmaceuticals

Hubei Guangji Pharmaceutical

Ningxia Qiyuan Pharma

Hebei Shengxue Dacheng

Xinfa Pharmaceutical